antibody

Documents about antibody

• A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer#332751ClinicalTrials.gov
• Case Report: A case of paraneoplastic autoimmune encephalitis with concurrent anti-GABABR and anti-SOX1 antibody positivity.#396228NCBI PubMed Central
• Monoclonal antibody dispensing during and around pregnancy: a descriptive analysis using electronic health records in Italy#398624Europe PMC
• Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer#424169ClinicalTrials.gov
• Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.#452922NCBI PubMed Central
• Treatment of antibody-mediated rejection in heart transplantation: from empirical combination to multi-target precision intervention.#465090NCBI PubMed Central
• Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans#683125ClinicalTrials.gov
• Clinical Prognostic Factors Associated With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Multicenter Cohort Study#684638Europe PMC
• Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer#803694ClinicalTrials.gov
• HepB mAb19 in Individuals With Chronic Hepatitis B Infection#805140ClinicalTrials.gov
• A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma#829518ClinicalTrials.gov
• Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2#829929ClinicalTrials.gov
• Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）#831539ClinicalTrials.gov
• Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma#833118ClinicalTrials.gov
• Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE#833165ClinicalTrials.gov
• PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer#841636ClinicalTrials.gov
• CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients#841900ClinicalTrials.gov
• Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.#844504ClinicalTrials.gov
• Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis#853989ClinicalTrials.gov
• Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer#860522ClinicalTrials.gov
• Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody#870379ClinicalTrials.gov
• Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation#874896ClinicalTrials.gov
• Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)#875802ClinicalTrials.gov
• Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos#890084ClinicalTrials.gov
• Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas#891020ClinicalTrials.gov
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis#831742ClinicalTrials.gov
• A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma#851534ClinicalTrials.gov
• XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures.#738NCBI PubMed Central
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer#67894ClinicalTrials.gov
• Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors#67900ClinicalTrials.gov
• LM-QASAS: Reference-free identification of antigen-specific sequences from the BCR repertoire using antibody language models#146516bioRxiv / medRxiv
• Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges.#152247NCBI PubMed Central
• Impact of process impurities on developability assessments of complex antibody formats: the striking role of leachable copper.#186006NCBI PubMed Central
• Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants#226340ClinicalTrials.gov
• Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma#252986ClinicalTrials.gov
• CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers#257561HAL (France)
• NMR detects clustering and ultra-weak excipient interactions governing monoclonal antibody viscosity in formulation-relevant conditions.#285108NCBI PubMed Central
• High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination#288108HAL (France)
• EXCIPIENTS FOR ENHANCING MONOCLONAL ANTIBODY STABILITY IN ORAL SOLID DOSAGE FORMS#288533ScholarBank@NUS
• Programmed death 1 antibody drug conjugates (PD 1 ADCs): Innovations in overcoming resistance and enhancing immune mediated antitumor activity.#295168NCBI PubMed Central
• The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine Development#295598PubMed Central
• A side-by-side biophysical comparison of five single-domain antibody scaffolds used for synthetic display libraries.#305149NCBI PubMed Central
• Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma#311191ClinicalTrials.gov
• Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody.#322962NCBI PubMed Central
• Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer#332732ClinicalTrials.gov
• Antibody-drug conjugate-related marker heterogeneity between primary tumors and metastatic lymph nodes in advanced urothelial cancers.#334739NCBI PubMed Central
• The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis.#340450NCBI PubMed Central
• Superantigen-driven polyfunctional CD4+ T follicular regulatory cells impair tonsillar plasmablast function and class-switched antibody production#374143Europe PMC
• T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy#387697Europe PMC
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)#405219ClinicalTrials.gov